CBG, or cannabigerol, is a cannabinoid found in the cannabis plant. It is often referred to as the "mother of all cannabinoids" and is non-psychoactive, meaning it does not produce the "high" associated with THC. CBG interacts with the cannabinoid receptors in the brain and has been found to have potential therapeutic benefits, including fighting inflammation, pain, nausea, and slowing the proliferation of cancer cells. Research has also shown that CBG significantly reduces intraocular eye pressure caused by glaucoma. Additionally, CBG may be beneficial in treating conditions such as inflammatory bowel disease, Crohn’s disease, and certain types of cancer. It is considered to be the precursor to other cannabinoids, as it breaks down to form CBD, THC, and other cannabinoids when heated. While CBG is becoming increasingly popular, research around it is still limited, and more studies are needed to fully understand its potential benefits and any potential side effects or interactions with medications.